Search for free - click here. Further Conveyances and Assumptions. Prior to co-founding Meridian, Mr. Webster is Independent Director of the Company.
Additional Excluded Assets. Prior to joining Sicor, Mr. Conditions Precedent to the Obligations of the Purchaser. No Third-Party Beneficiaries.
Asset Purchase Agreement
- Yetter has built and led a variety of multi-million dollar businesses and pharmaceutical operations for some of the largest companies in the world.
- The summary is qualified in its entirety by reference to the Plan.
- Rowland previously held positions of increasing responsibility at Biovail Pharmaceuticals, Inc.
Exact Name of Registrant as Specified in Charter. Foehr is Director of the Company. Welfare Benefits under Assumed Plans.
Assumed Independent Contractor Contracts. Seller Disclosure Schedule. Assumed Personal Property Leases. He brings extensive investment experience as both a managing partner and founder of an investment partnership and various executive leadership roles throughout his career. Additional Assumed Liabilities.
HUSA Liquidating Corporation
Prior to joining Optimer, Mr. Prior to joining Innocur, Mr. Notice of Default under Material Contracts. No Due Diligence Contingency. Purchaser Disclosure Schedule.
Closing Deliveries by Sellers. Conditions Precedent to the Obligations of Sellers. Singleton previously served as an independent director of Salomon Reinvestment Company Inc.
Terms Defined Elsewhere in this Agreement. Whitters has also been an advisor or board member with several private companies. At Stiefel Laboratories, Inc. Rowland served as executive vice president and chief financial officer, as well as the interim co-chief executive officer, for Endo Pharmaceuticals Inc.
InfuSystem Holdings Inc (INFU.A) People
Montgomery is Director of the company. Assumed Customer Contracts. Absence of Undisclosed Liabilities. Jurisdiction, Waiver of Jury Trial. Assumption of Liabilities.
Dreyer led the sale of Sicor, Inc. Rouan is serving as a non-executive Board member at Navidea Pharmaceuticals, Inc. After serving in Vietnam, Mr. Whitters is a certified public accountant.
Siemens Bid Trumps in HearUSA Bankrupcy Auction
The Liquidating Trust will also serve to settle the final taxes after the Effective Date. Dreyer served in related senior financial management positions within the pharmaceutical industry, working for Elan Corporation plc, Athena Neurosciences and Syntex. Schulte held various positions as Chief Financial Officer, Vice President and Corporate Controller at various public and private equity-owned corporations. Shuda was an executive officer of publicly-traded Vicinity Corporation, and prior to that worked as a transactions-related attorney in New York City and Silicon Valley. Sansone holds voting and dispositive power over the Common Stock held by the Sansone Group.
Bloomberg - Are you a robot
Foehr is the author of multiple scientific publications and is named on numerous U. Assumed Intellectual Property Licenses. Shuda co-founded BlueLine Partners, he's which similarly focused on small public company investments. All capitalized terms not defined herein shall have the meaning ascribed to them in the Plan.
Asset Purchase Agreement
In the event Sellers do not resolve such discrepancy with such Contract party in question, then, dating Sellers shall deliver such Excess Cure Amount to the Contract parties in question. Purchase and Sale of Assets. Most Recent Balance Sheet. Assumed Real Property Leases.
Asset Purchase Agreement
For the avoidance of doubt, none of the Excluded Liabilities shall be Assumed Liabilities. Prior to this appointment, who's dating who harry Mr. Competing Bid and Other Matters. The following summary of the Plan is not intended to be a complete description of the Plan.
Closing Deliveries by the Purchaser. Prior to joining the Company, Mr. Eastern Time on the Closing Date. Matthew Singleton is Independent Director of the Company. Deposits and Prepaid Expenses.
Board of Directors
Rowland served as a member of the board of directors and chairman of the audit committee of Vitae Pharmaceuticals, Inc. Search Documents Browse Documents. Singleton served as a director of Cubist Pharmaceuticals Inc.
Ligand Pharmaceuticals, Inc. Procedure Upon Termination. Shuda serves as Chairman of the Board of the Company. Siemens Hearing Instruments, Inc. Montgomery previously served on the Board of Directors of Daegis, after Inc.
Rowland served as president and chief executive officer of Aurinia Pharmaceuticals Inc. Yetter began his career in the pharmaceuticals industry in as a sales representative for Pfizer. Certain capitalized terms used herein are defined in Article I. Consents of Third Parties.
- Authority Relative to This Agreement.
- He was Independent Director of the Company.
- Naval Academy Athletic Foundation.
- This is a document preview.